TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
HRTX

Heron Therapeuti

Healthcare · Biotechnology

0.29$ -0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Heron Therapeuti (HRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 38 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HRTX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
31 34 35 36 33 41 39 37 38 41 35 38 151
18 9.9 8.4 11 9.5 10 8.5 9.9 15 7.6 11 12 45
13 24 26 26 23 31 30 27 23 33 24 26 106
14 11 4.6 4.4 4.5 3.2 2.3 2.9 3.5 3.7 2.4 2.7 12
12 11 15 14 12 12 13 14 14 13 12 11 51
38 35 31 32 28 26 27 29 27 33 29 28 117
-25 -10 -4.8 -6.4 -4.5 4.2 3.2 -1.6 -4.1 0.0 -4.8 -2.0 -11
0.6 2.2 0.6 0.4 0.5 4.4 0.5 0.5 2.9 1.0 – – –
-25 -11 -3.2 -9.2 -4.8 3.7 2.6 -2.4 -17 -3.0 -8.1 -5.5 -34
0.8 0.3 0.6 – – – – – – – – – –
-25 -11 -3.2 -9.2 -4.8 3.7 2.6 -2.4 -17 -3.0 -8.1 -5.5 -34
-24 -5.6 -1.9 -8.2 -3.8 8.7 3.7 -1.8 -14 -0.8 -7.6 -5.5 -28

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?